1. |
中华医学会肿瘤学分会, 国家卫生健康委员会医政司. 中国直肠癌诊疗规范(2023版). 协和医学杂志, 2023, 14(4): 706-733.
|
2. |
汪晓东, 刘健博, 李立. 数据库建设第六部分: 直肠癌分期的标签与结构化. 中国普外基础与临床杂志, 2020, 27(7): 873-879.
|
3. |
汪晓东, 曾渝, 李立. 数据库建设第十部分: 直肠癌辅助治疗的标签与结构化. 中国普外基础与临床杂志, 2021, 28(8): 1070-1077.
|
4. |
汪晓东, 朱佳怡, 李立. 数据库建设第十一部分: 直肠癌随访的标签与结构化. 中国普外基础与临床杂志, 2021, 28(10): 1353-1359.
|
5. |
余卫, 张在竹. 医学领域年龄人群划分标准浅析. 中国医学科学院学报, 2023, 45(2): 285-289.
|
6. |
Wang PH, Yang ST, Liu CH. Neoadjuvant therapy. J Chin Med Assoc, 2023, 86(2): 133-134.
|
7. |
Custers PA, van der Sande ME, Grotenhuis BA, et al. Long-term quality of life and functional outcome of patients with rectal cancer following a watch-and-wait approach. JAMA Surg, 2023, 158(5): e230146.
|
8. |
Bascoul-Mollevi C, Gourgou S, Borg C, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis. Eur J Cancer, 2023, 186: 151-165.
|
9. |
Mei WJ, Wang XZ, Li YF, et al. Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase Ⅲ trial. Ann Surg, 2023, 277(4): 557-564.
|
10. |
Dijkstra EA, Hospers GAP, Kranenbarg EM, et al. Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer — The RAPIDO trial. Radiotherapy and Oncology, 2022, 171: 69-76.
|
11. |
Koukourakis IM, Kouloulias V, Tiniakos D, et al. Current status of locally advanced rectal cancer therapy and future prospects. Crit Rev Oncol Hematol, 2023, 186: 103992.
|
12. |
李绍堂. [评论]新辅助化疗后延迟手术影响结直肠癌腹膜转移患者的生存: 一项BIG-RENAPE网络多中心研究. 结直肠肛门外科, 2023, 29(3): 285-286.
|
13. |
Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer-Verlag, 2017: 252-254.
|
14. |
韩晶, 王贵英, 张难, 等. 肿瘤部位及临床病理特征对不同TNM分期行结直肠癌根治性切除术患者预后的影响研究. 中国全科医学, 2020, 23(18): 2275-2283.
|
15. |
Lee L, Jannapureddy M, Albo D, et al. Outcomes of Veterans Affairs patients older than age 80 after surgical procedures for colon malignancies. Am J Surg, 2007, 194(5): 646-651.
|
16. |
Ahmed S, Howel D, Debrah S. The influence of age on the outcome of treatment of elderly patients with colorectal cancer. J Geriatr Oncol, 2014, 5(2): 133-140.
|
17. |
Nigri G, de’Angelis N, Baldini C, et al. Surgical and regional treatments for colorectal cancer metastases in older patients: A systematic review and meta-analysis. Plos One, 2020, 15(4): e0230914.
|
18. |
邹雨恒, 廖伟豪, 刘莹, 等. 结直肠癌患者年龄对长期生存预后可能有影响: 基于DACCA 数据库的真实世界分析. 中国普外基础与临床杂志, 2022, 29(6): 795-802.
|
19. |
黄坤, 何运胜, 赵攀, 等. 手术治疗对直肠小细胞神经内分泌癌患者预后影响的SEER数据库分析. 中国普外基础与临床杂志, 2023, 30(2): 179-184.
|
20. |
O’Connell JB, Maggard MA, Liu JH, et al. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum, 2004, 47(12): 2064-2069.
|
21. |
Brody JP, Li Q, Cai G, et al. Better long-term survival in young patients with non-metastatic colorectal cancer after surgery, an analysis of 69 835 patients in SEER database. PLoS ONE, 2014, 9(4): e93756.
|
22. |
Simmonds PD, Best L, George S, et al. Surgery for colorectal cancer in elderly patients: a systematic review. Lancet, 2000, 356(9234): 968-974.
|
23. |
van Leeuwen BL, Påhlman L, Gunnarsson U, et al. The effect of age and gender on outcome after treatment for colon carcinoma. Crit Rev Oncol Hematol, 2008, 67(3): 229-236.
|
24. |
Serra-Rexach JA, Jimenez AB, García-Alhambra MA, et al. Differences in the therapeutic approach to colorectal cancer in young and elderly patients. Oncologist, 2012, 17(10): 1277-1285.
|
25. |
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med, 2003, 348(17): 1625-1638.
|
26. |
Murphy TK, Calle EE, Rodriguez C, et al. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol, 2000, 152(9): 847-854.
|
27. |
Meyerhardt JA, Tepper JE, Niedzwiecki D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stageⅡand Ⅲ rectal cancer: Findings from intergroup trial 0114. J Clin Oncol, 2004, 22(4): 648-657.
|
28. |
Jaspan V, Lin K, Popov V. The impact of anthropometric parameters on colorectal cancer prognosis: A systematic review and meta-analysis. Crit Rev Oncol Hematol, 2021, 159: 103232.
|
29. |
Moon HG, Ju YT, Jeong CY, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol, 2008, 15(7): 1918-1922.
|
30. |
Lennon H, Sperrin M, Badrick E, et al. The obesity paradox in cancer: a review. Curr Oncol Rep, 2016, 18(9): 56.
|
31. |
Kwak HD, Ju JK, Kang DW, et al. Outcomes according to body mass index following laparoscopic surgery in patients with colorectal cancer. J Minim Access Surg, 2018, 14(2): 134-139.
|
32. |
Prizment AE, Flood A, Anderson KE, et al. Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev, 2010, 19(9): 2229-2237.
|
33. |
Zafar SY, Abernethy AP. Financial toxicity, PartⅠ: a new name for a growing problem. Oncology (Williston Park), 2013, 27(2): 80-81, 149.
|
34. |
Shankaran V, Unger JM, Darke AK, et al. S1417CD: a prospective multicenter cooperative group-led study of financial hardship in metastatic colorectal cancer patients. J Natl Cancer Inst, 2022, 114(3): 372-380.
|
35. |
Smith GL, Lopez-Olivo MA, Advani PG, et al. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw, 2019, 17(10): 1184-1192.
|